Progression of fibrosis in chronic liver diseases: time to tally the score (Q74127917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1 reference

title

Progression of fibrosis in chronic liver diseases: time to tally the score (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

main subject

chronic liver disease

0 references

author

Roberto G Romanelli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

M Pinzani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Magli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

764-767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

1 reference

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

The long-term pathological evolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Fibrosis in patients with chronic hepatitis C: detection and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Oxidative damage and fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Molecular Biology of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

HNE interacts directly with JNK isoforms in human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Liver fibrosis in overweight patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Effects of sex hormones on mesangial cell proliferation and collagen synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Sex and hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900055-1

7 January 2021

10.1016/S0168-8278(01)00055-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11434626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference